Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH
Clinical trial NCT05462353 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05462353
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2025-05-10
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.